All three projects (NanoInformaTIX, Gov4Nano, SUNSHINE) center on assessing and governing nanomaterial risks through different lenses — informatics, governance councils, and sustainable design.
EAST EUROPEAN RESEARCH AND INNOVATION ENTERPRISE LTD
Bulgarian SME specializing in nanomaterial safety assessment, safe-by-design strategies, and risk governance for advanced materials.
Their core work
EMERGE is a Bulgarian SME specializing in nanosafety — the science of making engineered nanomaterials safe for humans and the environment. They contribute to risk assessment frameworks, safe-by-design strategies, and computational modeling platforms (QSAR, PBPK, multi-scale models) that predict nanomaterial behavior without relying on animal testing. Their work sits at the intersection of regulatory science and nanotechnology, helping translate complex safety data into governance frameworks and technical guidance that regulators and industry can actually use.
What they specialise in
Gov4Nano and SUNSHINE both address safe-by-design and safe-and-sustainable-by-design approaches for nanomaterial development.
NanoInformaTIX and SUNSHINE involve multi-scale material modelling, QSAR, and systems biology models for predicting nanomaterial hazards.
NanoInformaTIX focuses on grouping and classifying engineered nanomaterials; SUNSHINE extends this to multi-component nanomaterials with read-across methods.
SUNSHINE explicitly targets adaptation of regulatory guidance and standards for advanced multi-component nanomaterials.
How they've shifted over time
EMERGE entered H2020 in 2019 with a dual focus: computational modeling platforms for nanomaterial classification (NanoInformaTIX) and risk governance frameworks (Gov4Nano). By 2021, their work shifted toward the more applied challenge of safe-and-sustainable-by-design strategies for advanced multi-component nanomaterials (SUNSHINE), with growing emphasis on regulatory adaptation. The trajectory shows a clear move from building assessment tools toward shaping how those tools feed into regulation and industrial practice.
EMERGE is moving from computational safety modeling toward regulatory translation — positioning itself as a bridge between nanosafety science and practical industry/regulatory implementation.
How they like to work
EMERGE operates exclusively as a participant in large Research and Innovation Action consortia, with an average of ~28 partners per project. With 84 unique partners across 26 countries from just three projects, they are embedded in the core European nanosafety research community rather than building a narrow set of repeat partnerships. This broad network suggests they bring a specific, valued competence that different consortia seek out.
Remarkably wide network for a small company: 84 unique consortium partners across 26 countries, built through three large nanosafety consortia. Their reach spans nearly all EU member states, indicating deep integration into the pan-European nanosafety research ecosystem.
What sets them apart
EMERGE is one of very few Eastern European SMEs embedded in the top-tier EU nanosafety consortia. As a private company rather than a university or research institute, they can translate between academic safety science and real-world regulatory and industrial needs — a gap most research-heavy consortia struggle to bridge. Their Bulgarian base also brings cost-effectiveness and access to emerging Eastern European manufacturing sectors where nanosafety guidance is increasingly needed.
Highlights from their portfolio
- SUNSHINELargest funding (EUR 356,910) and most recent project, tackling the frontier challenge of safe-by-design for advanced multi-component nanomaterials with direct regulatory impact.
- Gov4NanoFocused specifically on building a Risk Governance Council and governance framework for nanotechnology — unusual for an SME to be involved in policy-shaping infrastructure.
- NanoInformaTIXContributed to a sustainable nanoinformatics modelling platform integrating QSAR, PBPK, and systems biology — a computational backbone for the nanosafety field.